Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (NCT07220564) titled 'A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A' on Oct. 22.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Novo Nordisk A/S
Condition:
Haemophilia A
Intervention:
Drug: NNC0442-0344 A
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: October 23, 2025
Target Sample Size: 20
Countries of Recruitment:
United States
Austria
Germany
Italy
Poland
Spain
United Kingdom
Austria...